Glucagon-like peptide-1 (GLP-1) compounds have emerged as a compelling therapeutic target for managing metabolic disorders. These naturally occurring molecules are secreted by the gut in response to meal intake, https://zbookmarkhub.com/story20611501/unveiling-the-therapeutic-potential-of-glp-1-peptides